Show simple item record

dc.contributor.authorMorgan, Robert David
dc.contributor.authorClamp, Andrew R
dc.contributor.authorHasan, Jurjees
dc.contributor.authorMitchell, Claire L
dc.contributor.authorSaunders, Geoff
dc.contributor.authorMescallado, Nerissa
dc.contributor.authorWelch, Richard
dc.contributor.authorJayson, Gordon C
dc.date.accessioned2018-04-29T20:52:54Z
dc.date.available2018-04-29T20:52:54Z
dc.date.issued2018-03
dc.identifier.citationAn outpatient, dose-intense, intravenous cisplatin and oral etoposide regimen for the treatment of advanced, platinum-resistant ovarian cancer. 2018, 28(3): 448-452 Int J Gynecol Canceren
dc.identifier.issn1525-1438
dc.identifier.pmid29466253
dc.identifier.doi10.1097/IGC.0000000000001194
dc.identifier.urihttp://hdl.handle.net/10541/620922
dc.description.abstractAdvanced-stage, platinum-resistant, ovarian cancer can be treated with dose-intense chemotherapy; one such regimen includes intravenous cisplatin and oral etoposide. To minimize the toxicity associated with weekly cisplatin, pretreatment and posttreatment hydration is required, often necessitating inpatient, overnight admission. We report a shorter, within-day regimen for delivering weekly cisplatin.
dc.language.isoenen
dc.rightsArchived with thanks to International journal of gynecological cancer : official journal of the International Gynecological Cancer Societyen
dc.titleAn outpatient, dose-intense, intravenous cisplatin and oral etoposide regimen for the treatment of advanced, platinum-resistant ovarian cancer.en
dc.typeArticleen
dc.contributor.departmentThe Christie Hospital NHS Foundation Trust, Manchester, United Kingdomen
dc.identifier.journalInternational Journal of Gynecological Canceren
html.description.abstractAdvanced-stage, platinum-resistant, ovarian cancer can be treated with dose-intense chemotherapy; one such regimen includes intravenous cisplatin and oral etoposide. To minimize the toxicity associated with weekly cisplatin, pretreatment and posttreatment hydration is required, often necessitating inpatient, overnight admission. We report a shorter, within-day regimen for delivering weekly cisplatin.


This item appears in the following Collection(s)

Show simple item record